Cromwell Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History

Cromwell Holdings’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$213K	Hold	342	–	–	0.1%	190
2026 Q1	$264K	Hold	342	–	–	0.15%	135
2025 Q4	$264K	Hold	342	–	–	0.14%	134
2025 Q3	$192K	Buy	342 +241	+239%	+$136K	0.1%	191
2025 Q2	$53K	Sell	101 -208	-67%	-$116K	0.03%	449
2025 Q1	$196K	Buy	309 +76	+33%	+$52.3K	0.13%	155
2024 Q4	$166K	Hold	233	–	–	0.1%	194
2024 Q3	$245K	Hold	233	–	–	0.16%	131
2024 Q2	$245K	Buy	+233	New	+$226K	0.15%	125

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

Cromwell Holdings's REGN Position: Q2 2026 in Review

Cromwell Holdings held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 342 shares worth $213K. The position accounts for 0.1% of the portfolio, ranked #190.

Cromwell Holdings first reported a position in REGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $264K in Q1 2026. 298 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Cromwell Holdings held 342 shares of Regeneron Pharmaceuticals worth $213K as of Q2 2026.
Cromwell Holdings left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
Regeneron Pharmaceuticals made up 0.1% of Cromwell Holdings's portfolio in Q2 2026, its #190 holding.
Cromwell Holdings first reported a position in Regeneron Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
Cromwell Holdings's Regeneron Pharmaceuticals position peaked at $264K in Q1 2026.
298 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.